Kresko RNAtech
Kresko RNAtech is an Argentina-based biotech company that develops and commercializes bioactive RNA ingredients — derived from fresh foods and stabilized via proprietary technology — for B2B customers in the dietary supplements, cosmetics, and functional foods industries, using its AI-powered Serkanto discovery platform.
- Company typePrivate
- Founded2021
- HeadquartersBuenos Aires, Argentina
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Kresko RNAtech does
Kresko RNAtech is an Argentina-based biotechnology company founded in 2021 that develops and commercializes bioactive RNA ingredients derived from fresh foods for the dietary supplements, beauty/cosmetics, and functional foods and beverages industries. The company's scientific premise is that food industrialization has stripped bioactive RNAs — molecules that act as 'information carriers' regulating cellular function, metabolism, and stress response — from the modern diet, since these molecules degrade within 24 hours of harvest. Kresko addresses this through two proprietary technical pillars: (1) the Serkanto AI platform, which uses machine learning, deep learning, and bioinformatics pipelines to identify and validate bioactive RNAs across more than 10,000 species and over 350,000 mapped RNA candidates; and (2) a proprietary RNA stabilization technology built entirely from food-grade ingredients that preserves molecular integrity through industrial processing. The platform has demonstrated 88% prediction accuracy for milk-derived bioactives and supports a cell-based assay platform with 20+ validated assays deliverable in approximately two weeks.
The company operates a B2B ingredient supplier business model, offering three trademarked commercial ingredients — DormoRNA® (milk-derived, for sleep), JunaRNA® (milk-derived, for skin regeneration), and TikaRNA® (plant-derived nettle, for skin renewal and microbiome balance) — alongside the Serkanto platform as a discovery and co-development service. Commercial engagement ranges from short discovery sprints (1–2 months) through full co-development programs (2–6 months), with pricing not publicly disclosed. Kresko serves CPG customers across three primary verticals and reports inbound interest from over 50 CPG companies, with no customer logos publicly disclosed. Products are Self-GRAS affirmed and Non-GMO verified.
Kresko is led by three co-founder PhDs (Carla Borini Etichetti as CEO, Uciel Chorostecki as CTO, Silvana Spinelli as CSO) operating with 1–10 employees across Argentina and the United States. The company is venture-backed by SOSV (through IndieBio) and GRIDX, supported by accelerators including Parallel18, Scale2Miami, and the Singapore BIG incubation program, and has received recognition including four consecutive years on the FoodTech 500 (through 2026), finalist status at the Global Food Tech Awards in both 2025 and 2026, and selection as a Hello Tomorrow Deep Tech Pioneer for 2026. As of April 2026, Kresko is actively raising $500,000 with 40% already committed.
Kresko RNAtech firmographics
Firmographics- Name
- Kresko RNAtech
- Legal name
- Kresko RNA Tech
- Website
- https://kreskornatech.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Kresko RNAtech is an Argentina-based biotech company that develops and commercializes bioactive RNA ingredients — derived from fresh foods and stabilized via proprietary technology — for B2B customers in the dietary supplements, cosmetics, and functional foods industries, using its AI-powered Serkanto discovery platform.
- Ownership category
- akta.pro rank
Kresko RNAtech industry classification
Industry- Product category
- Bioactive Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411), Food Manufacturing (311)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics) (HLAAADAG)
- akta.pro secondary industries
- RNA Chemistry & Oligonucleotide Engineering (backbones, modifications, stereochemistry) (HLAAADAE), RNA Therapeutics Safety & Immunogenicity (innate immune activation, tox, off-target) (HLAAADAI)
Keywords
Where Kresko RNAtech is headquartered
LocationHeadquarters
- HQ city
- Buenos Aires
- HQ country
- Argentina
- HQ region
- Latin America
Offices2 records
Markets served
Kresko RNAtech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Bioactive RNA Ingredients B2B Sales: Kresko supplies bioactive RNA ingredients to food, supplement, and cosmetics companies for integration into their products. The company offers ingredient solutions at various collaboration levels - from discovery sprints (1-2 months) to full product development (2-6 months) to fully customized R&D roadmaps.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Kresko RNAtech product offering
Product offeringCore offering
Kresko RNAtech develops, stabilizes, and supplies bioactive RNA ingredients derived from fresh foods (milk and plants) for integration into dietary supplements, functional foods/beverages, and cosmetic products. Its portfolio includes three branded ingredient products — DormoRNA (sleep support), JunaRNA (skin regeneration), and TikaRNA (skin renewal) — discovered and validated through its proprietary Serkanto AI bioinformatics platform and stabilized using a natural food-grade buffer that preserves RNA molecules that otherwise degrade within 24 hours of harvest.
Product overview
Kresko RNAtech is a biotechnology company that has developed a proprietary technology to isolate, stabilize, and commercialize bioactive RNAs from fresh foods. The company offers a portfolio of three validated RNA-based ingredient products (DormoRNA® for sleep, JunaRNA® for skin regeneration, and TikaRNA® for skin health) powered by their AI-driven Serkanto platform. The platform enables discovery, biological validation, and production of bioactive RNAs for dietary supplements, functional foods and beverages, and cosmetics industries.
Differentiator
Problem solved
Functional benefit
Brands
- DormoRNA®: Milk-derived RNA ingredient designed to promote relaxation and restful sleep by improving gut health and enhancing serotonin production.
- JunaRNA®
- TikaRNA®
Products and services
- Serkanto AI (Serkanto-AI) AI-powered bioinformatics platform that uses machine learning and deep learning to identify and validate bioactive RNAs in medicinal plants, fungi, and fresh foods, offered to CPG R&D teams for tailored on-demand collaboration to develop customized RNA-based products.
- DormoRNA Milk-derived RNA extract designed for sleep support supplements; promotes relaxation by lowering cortisol and increasing serotonin, supports gut health by preserving intestinal barrier integrity, improves REM sleep duration, and is non-habit forming. Available in liquid and powder forms for dietary supplements, sleep capsules, bedtime snacks, and night-time beverages.
- JunaRNA Milk RNA-rich extract for skincare; scientifically validated to accelerate skin turnover by 2 days in treated areas, promote wound healing, stimulate extracellular matrix production by fibroblasts, and improve skin cell renewal. Available in liquid or powder form for topical creams and serums.
- TikaRNA Plant-based RNA ingredient derived from fresh nettle (Urtica dioica); scientifically validated to promote faster cellular turnover and microbiome balance, reduce inflammatory markers via specific bioactive RNAs, and support skin probiotic activity by boosting Lactobacillus species growth. Solvent-free formulation for regenerative facial creams, serums, post-treatment gels, barrier repair balms, and overnight masks.
Quantifiable outcome
- 88% accuracy in bioactive RNA predictions for milk
- +3 more outcomes
Companies that use Kresko RNAtech
Customer profileSegments3 records
Ideal customer profiles3 records
Kresko RNAtech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature6 records
Kresko RNAtech partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered major, minor and core.
- Parallel18majorPuerto Rico-based accelerator program Gen13 that Kresko was selected to join. Provides access to mentors, startup community, and expansion opportunities.
- World Agri-Tech South AmericaminorSummit participation for agri-food tech ecosystem networking and visibility.
- BCR (Bolsa de Comercio de Rosario) Startup NetworkmajorPrestigious initiative by Rosario Board of Trade connecting cutting-edge startups with agribusiness and technology players. Kresko was among 25 selected startups.
- Nestlé Health SciencemajorNamed as participant in Innovate Forward: The Healthy Aging Challenge created by Nestlé Health Science in collaboration with Tufts University. Strategic recognition for healthy aging innovation.
- Tufts University - Friedman School of Nutrition Science and PolicymajorCollaboration through Tufts Food & Nutrition Innovation Institute for the Innovate Forward: The Healthy Aging Challenge.
- La CanduchacoreDairy farm partnership providing fresh milk for bioactive RNA extraction. Alliance origin story highlights the collaboration needed to source quality raw material.
- Plug and PlayminorMentored by Plug and Play, a global innovation platform connecting startups with major corporations.
- MassChallengeminorMentored by MassChallenge, a global network of accelerators.
- Endeavor GlobalminorMentored by Endeavor Global, supporting high-impact entrepreneurs.
- Future Food-TechminorEvent organizer for Innovation Showcase at Future of Food Seminars in São Paulo.
- Tim Carroll (Advisory Board)majorAdded to Advisory Board with over 20 years experience developing and scaling functional ingredients globally, including leadership at Fonterra.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Kresko RNAtech competitors and assessment
Company assessmentDirect peers
- Brightseed: Brightseed operates an AI-driven discovery platform (Forager) that maps bioactive compounds in plants and foods for health and nutrition applications. It is directly comparable to Kresko in applying AI/bioinformatics to identify bioactives from natural sources for CPG and supplement customers.
- Nuritas: Nuritas uses AI and peptideomics to discover bioactive peptides from food sources for health, wellness, and personal care. Comparable to Kresko as an AI-driven ingredient discovery company targeting supplements, functional food, and cosmetics with scientifically validated natural bioactives.
- Shiru: Shiru is an AI-powered ingredient discovery company that mines natural proteins for food and personal care applications. Comparable to Kresko as a B2B ingredient platform using machine learning to identify and validate novel natural bioactives for CPG customers.
- Ayana Bio: Ayana Bio produces plant cell-cultivated bioactive ingredients for health and wellness products using a precision biology platform. Comparable to Kresko as a science-led developer of novel bioactives for supplements and functional nutrition customers.
- Geltor: Geltor produces animal-free proteins and bioactive ingredients for nutrition and skincare using a precision fermentation platform. Comparable to Kresko as a B2B supplier of science-backed, next-generation bioactives targeting CPG and cosmetics customers.
Broad incumbents
- NotCo: NotCo applies AI (Giuseppe) to discover plant-based ingredient combinations for food and beverage products. Broader incumbent in AI-driven food ingredient innovation with a downstream product focus, but the underlying platform thesis of AI-identified natural bioactives overlaps with Kresko's approach.
- Perfect Day: Perfect Day produces animal-free dairy proteins via precision fermentation for food, nutrition, and skincare customers. Comparable to Kresko as a supplier of biologically-derived, non-traditional ingredients to CPG, though at a much larger scale and with broader formulation reach.
Emerging players
- BioHarvest Sciences: BioHarvest Sciences uses plant cell cultivation to produce bioactives for nutrition, sports, and wellness markets. Comparable to Kresko as a developer of novel, plant-derived bioactives for supplement and wellness customers using proprietary bio-production platforms.
- Computable Labs: Computable Labs applies machine learning and laboratory automation to accelerate development of new food ingredients and materials. Comparable to Kresko as an early-stage AI-led ingredient discovery and development company in the food/CPG space.
- Plantible Foods: Plantible Foods develops a plant-based functional protein ingredient (rubin) for food and beverage applications using a proprietary cultivation process. Comparable to Kresko as a B2B supplier of novel, science-backed functional ingredients from natural sources targeting CPG customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Kresko RNAtech social profiles
Digital presenceKresko RNAtech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Kresko RNAtech leadership team
Management profileNumber of profiles
Profiles3 records
Kresko RNAtech funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Kresko RNAtech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Kresko RNAtech
What does Kresko RNAtech do?
Kresko RNAtech develops, stabilizes, and supplies bioactive RNA ingredients derived from fresh foods (milk and plants) for integration into dietary supplements, functional foods/beverages, and cosmetic products. Its portfolio includes three branded ingredient products — DormoRNA (sleep support), JunaRNA (skin regeneration), and TikaRNA (skin renewal) — discovered and validated through its proprietary Serkanto AI bioinformatics platform and stabilized using a natural food-grade buffer that preserves RNA molecules that otherwise degrade within 24 hours of harvest.
Is Kresko RNAtech a public or private company?
Kresko RNAtech is a private company. It is classified as venture growth investor backed and is currently operating.
When was Kresko RNAtech founded?
Kresko RNAtech was founded in 2021. It employs 1 to 10 people.
Where is Kresko RNAtech based?
Kresko RNAtech is headquartered in Buenos Aires, Argentina, in the Latin America region.
How does Kresko RNAtech make money?
One revenue line is on record: bioactive RNA Ingredients B2B Sales.
Who are Kresko RNAtech's main competitors?
Direct peers on record are Brightseed, Nuritas, Shiru, Ayana Bio and Geltor. Broad incumbents are NotCo and Perfect Day. Emerging players are BioHarvest Sciences, Computable Labs and Plantible Foods.
Does Kresko RNAtech have an API?
No public API is recorded for Kresko RNAtech.
What industry is Kresko RNAtech in?
Kresko RNAtech's product category is Bioactive Nutraceutical Ingredients. Its primary akta.pro industry code is HLAAADAG, RNA Therapeutics Platforms & Design (sequence design, target ID/validation, AI/bioinformatics), with a secondary code of HLAAADAE, RNA Chemistry & Oligonucleotide Engineering (backbones, modifications, stereochemistry). Its NAICS code is 325411 and its SIC code is 2833.